Header Logo

Connection

Patrick Arbuthnot to Dose-Response Relationship, Drug

This is a "connection" page, showing publications Patrick Arbuthnot has written about Dose-Response Relationship, Drug.
  1. In vitro transcribed mRNA for expression of designer nucleases: Advantages as a novel therapeutic for the management of chronic HBV infection. Adv Drug Deliv Rev. 2021 01; 168:134-146.
    View in: PubMed
    Score: 0,173
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.